BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201207
DTEND;VALUE=DATE:20201211
DTSTAMP:20260403T200658
CREATED:20201029T160029Z
LAST-MODIFIED:20201128T210915Z
UID:4523-1607299200-1607644799@carb-x.org
SUMMARY:Milken Institute Future of Health Summit
DESCRIPTION:The Milken Institute Future of Health Summit convenes the best minds in the world to confront the most significant health challenges by matching human\, financial\, scientific\, and educational resources with innovative and impactful ideas. The Summit will focus on the converging crises of public health\, economic insecurity\, and social injustice. COVID-19 has exposed weaknesses across our health systems\, particularly in the treatment of our most vulnerable communities\, where access to affordable and quality health care has never been more vital. \nParticipants include Kevin Outterson\, Executive Director of CARB-X\, who will be moderating a session entitled “Are Resistant Infections the Next Pandemic? New Antibiotics Need New Incentives” on Tuesday\, December 8th from 12:00pm – 1:00pm EST. \nAre Resistant Infections the Next Pandemic? New Antibiotics Need New Incentives: Antibiotic treatment in COVID-19 patients is driving antimicrobial resistance (AMR) as secondary infections emerge. While large pharmaceutical companies have retreated from antibiotic development\, smaller enterprises have compensated with innovative therapies to ensure an arsenal of anti-infective drugs. But numerous recent bankruptcies show that times are tough even for companies with newly approved antibiotics. Several large pharmaceutical companies recently joined in launching the billion-dollar Antimicrobial Action Fund for antibiotic development. This welcome investment buys time to right the market\, but it is clear that a pull incentive is needed to drive the market. What are the lessons to learn from the UK NHS NICE subscription-model pilot? Is a pull incentive enough to attract private investment to antimicrobials? How can we develop a sustainable market for antibiotics so that drug-resistant infections do not become the next pandemic? \nSpeakers Include: \n\nMichael Boyle\nPresident and CEO\, Cystic Fibrosis Foundation\nNick Crabb\nProgramme Director\, Scientific Affairs\, National Institute for Health and Care Excellence (NICE)\nSally Davies\nUK Special Envoy on Antimicrobial Resistance\, UK Government\nOdysseas Kostas\nPartner and Senior Managing Director\, Sarissa Capital\n\nTo learn more\, click here.\nTo view the program\, click here.
URL:https://carb-x.org/event/milken-institute-future-of-health-summit/
LOCATION:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201207
DTEND;VALUE=DATE:20201212
DTSTAMP:20260403T200658
CREATED:20201202T232424Z
LAST-MODIFIED:20201202T232424Z
UID:4665-1607299200-1607731199@carb-x.org
SUMMARY:2020 ASM Conference on Next-Generation Sequencing
DESCRIPTION:Join us at the virtual 2020 ASM Conference on Next-Generation Sequencing\, taking place Dec. 7-11\, 2020\, and get comprehensive guidance with up-to-date examples in the use of NGS technology for applied results in the traceability and clustering of microbial pathogens associated with food safety\, clinical infection\, environmental contamination and other potential sources of disease outbreaks. You’ll walk away with access to the available resources and direction you need relating to bioinformatics and epidemiology. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/2020-asm-conference-on-next-generation-sequencing/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201208
DTEND;VALUE=DATE:20201211
DTSTAMP:20260403T200658
CREATED:20201112T203844Z
LAST-MODIFIED:20220803T215834Z
UID:4573-1607385600-1607644799@carb-x.org
SUMMARY:BLUE KNIGHT™ Symposium
DESCRIPTION:CARB-X participants include Erin Duffy\, Chief of R&D. \nJohnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA)\, a component of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services\, to form Blue Knight. This collaboration aims to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases. Find out more about BARDA and its mission at www.PHE.gov/BARDA. \nIn seeking to combat emerging infectious diseases and other 21st century health threats\, the path to better prepared\, protected\, and healthy individuals\, families\, and communities could rely on unlocking the collective power of the global community. BLUE KNIGHT™ seeks to answer this call. \nOn December 8-10\, Johnson & Johnson Innovation – JLABS and BARDA will virtually convene the emerging Blue Knight community of thought leaders\, innovators and entrepreneurs for a three-day symposium\, including interactive sessions focused on key areas of interest in infectious disease\, public health\, and company acceleration. Sessions will explore high priority areas of interest for scientific and technological innovation aimed for improving our preparedness and response to emerging health security threats. \nTo learn more\, click here.\nTo register\, click here.
URL:https://carb-x.org/event/blue-knight-symposium/
LOCATION:Virtual Event\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
END:VCALENDAR